Categories
-
Adhesives
6
Amines
115
Amino Acids
208
Analytical Reagents
751
Antibiotics
271
Bioactive Small Molecules
801
Aroma Chemicals
247
Biochemicals
1151
Boronic Acids
4
Buffers
104
Building Blocks
2175
Carbohydrates
192
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
63
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
237
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
358
Ion-Pair Reagents
23
Ligands
81
Organics
1637
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
68
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
890
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
323
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
19
Water Analysis
13
Escitalopram oxalate
(86905726 | 219861-08-2)
CAS: | 219861-08-2 |
---|---|
Molecular Formula: | C20H21FN2O · C2H2O4 |
Molecular Weight: | 414.43 |
Availablility: | In Stock |
---|---|
Downloads: | | |
86905726-1g | 1g | £176.20 | |
Bulk Order |
86905726-1g | 1g | €246.70 | |
Bulk Order |
86905726-1g | 1g | $264.30 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 86905726 | ||||
Product Name | Escitalopram oxalate | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 219861-08-2 | ||||
Molecular Formula | C20H21FN2O · C2H2O4 | ||||
Molecular Weight | 414.43 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 2932990090 |
Product Specification
Melting Point | 148.5 - 152.5 Deg C | ||||
Specific rotation | +12 to +13.5 | ||||
Heavy metals | <10ppm | ||||
pH | 2 - 4 | ||||
Loss on Drying | <0.5% | ||||
Assay | 99% min | ||||
Residue on Ignition | <0.1% | ||||
Individual impurity | <0.2% | ||||
Total Impurities | <0.5% | ||||
Appearance | White crystalline powder |
Safety Information
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|